1. Home
  2. TG vs KROS Comparison

TG vs KROS Comparison

Compare TG & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.05

Market Cap

239.6M

Sector

Industrials

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.64

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
KROS
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.6M
206.0M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TG
KROS
Price
$7.05
$11.64
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $21.86
AVG Volume (30 Days)
136.5K
★ 157.6K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 151.06
146.00
EPS
★ 0.34
N/A
Revenue
★ $800,821,000.00
$243,864,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,751.79
P/E Ratio
$20.74
★ N/A
Revenue Growth
★ 8.29
N/A
52 Week Low
$6.25
$9.69
52 Week High
$10.53
$22.55

Technical Indicators

Market Signals
Indicator
TG
KROS
Relative Strength Index (RSI) 41.39 57.43
Support Level $6.42 $10.59
Resistance Level $8.10 $12.35
Average True Range (ATR) 0.24 0.45
MACD -0.00 0.03
Stochastic Oscillator 44.79 69.63

Price Performance

Historical Comparison
TG
KROS

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: